Fmoc-L-Ser(Me)-OH

Fmoc-L-Ser(Me)-OH is an Fmoc-protected, L-serine-derived amino acid bearing a methyl-substituted side-chain, where the hydroxymethyl group of serine is converted to a methoxy-methyl (Me) substituted alcohol equivalent, resulting in a functional side chain that can participate in hydrogen-bonding and derivatization chemistry. The molecule contains a chiral α-carbon characteristic of L-amino acid stereochemistry, a carbamate-forming Fmoc protecting group on the α-amino functionality, and a carboxylic acid suitable for peptide coupling or conversion to activated intermediates. The presence of a side-chain oxygen and the embedded methyl substituent modulate polarity and steric environment relative to unmodified serine, while the Fmoc group provides orthogonal protection compatible with standard solid-phase and solution-phase peptide synthesis workflows. The compound therefore serves as a chiral amino acid building block and protected amino acid intermediate for constructing peptides and peptidomimetic scaffolds with controlled side-chain functionality.

1. Peptide Synthesis

Fmoc-L-Ser(Me)-OH is used in peptide building block preparation where the Fmoc carbamate protects the α-amine during chain assembly and can be removed under base conditions to enable sequential peptide bond formation. The L-configuration at the α-carbon and the carboxylic acid enable coupling to activated carboxyl derivatives or activated esters, supporting stereochemically defined peptide chain growth. The side-chain oxygen functionality, shaped by the Me substitution, can influence local conformation and reactivity during peptide assembly and subsequent functional group transformations. Downstream use includes synthesis of serine-methyl analog peptides for studying how side-chain substitution affects backbone packing, hydrogen-bond networks, and coupling/cleavage behavior in synthetic peptide workflows.

2. Side-Chain Functionalization

Fmoc-L-Ser(Me)-OH supports amino acid derivatization strategies targeting side-chain oxygen chemistry, where the protected α-amino group allows selective manipulation of the side chain after Fmoc removal. The methyl-substituted serine side chain can be converted into additional functional handles via oxygen-based transformations, enabling formation of ether, ester, or other oxygen-linked motifs that are compatible with peptide conjugation schemes. The controlled stereochemistry of the L-amino acid center helps maintain predictable spatial presentation of the modified side chain within larger peptide or peptidomimetic constructs. Resulting derivatives can serve as intermediates for chemical biology probes, affinity reagents, and structure-encoded peptide analogs produced through iterative functional group installation.

3. Chemical Biology Probes

Fmoc-L-Ser(Me)-OH is applied in chemical biology research and biomolecule labeling workflows where incorporation into peptides or peptide-like ligands enables controlled display of a serine-derived oxygen motif with altered steric and electronic properties. The Fmoc-protected amino acid form facilitates incorporation into defined sequences, while the side-chain Me substitution can tune reactivity toward conjugation chemistries that rely on oxygen-containing functional groups. The chiral α-center ensures stereochemical fidelity in probe scaffolds, supporting reproducible molecular recognition in downstream assays and binding studies. Labeled or functionalized peptide constructs prepared from this building block can be used as research intermediates for mapping interaction interfaces, validating target engagement motifs, and generating reagent libraries for biochemical investigations.

4. Peptidomimetics And SAR

Fmoc-L-Ser(Me)-OH is suitable for peptidomimetic construction and structure-activity relationship studies where side-chain modification of serine analogs helps probe how oxygen placement and methyl substitution affect activity-relevant conformations. The Fmoc-protected α-amine provides a protected amino acid chemistry platform for assembling analogs with consistent stereochemistry, while the carboxylic acid supports iterative coupling to generate multi-residue scaffolds. The Me-substituted side chain can alter hydrogen-bonding patterns and steric bulk compared with standard serine, enabling systematic SAR exploration across closely related peptide analogs. Downstream, this building block can be converted into higher-order analogs such as cyclized peptides, constrained peptidomimetics, or fragment-based modules used to refine binding hypotheses in medicinal chemistry programs.

5. Pharmaceutical Intermediate Preparation

Fmoc-L-Ser(Me)-OH is employed as a protected amino acid intermediate in pharmaceutical manufacturing-oriented fine chemical synthesis where Fmoc protection supports controlled peptide fragment assembly and purification workflows. The orthogonal nature of the Fmoc group enables deprotection and coupling steps that are compatible with scalable peptide synthesis strategies, while the defined L-stereochemistry supports reproducible intermediate formation. The methyl-substituted side-chain oxygen can be carried through intermediate stages and later transformed into desired functional groups for producing peptide-based active ingredients or peptide-derived intermediates. Resulting materials can serve as standardized chiral building blocks for generating peptide fragments, conjugation-ready intermediates, and process-compatible precursors in industrial chemical manufacturing chains.

6. Process Chemistry Intermediate

Fmoc-L-Ser(Me)-OH can be used in process chemistry intermediate preparation where the stable Fmoc-protected amino acid format supports predictable handling during activated ester formation and peptide fragment coupling. The molecule's carboxylic acid and protected amine allow conversion into coupling-ready derivatives under industrially relevant conditions, while the chiral L-center helps maintain stereochemical integrity through downstream synthetic steps. The side-chain oxygen functionality, modulated by the Me substituent, can be leveraged for controlled downstream derivatization without requiring complete side-chain protection strategies at every stage. The resulting process intermediates can be incorporated into larger peptide assemblies, enabling manufacturing routes for defined amino acid sequences and functionalized peptide analogs used in applied chemical production and biochemical research material generation.

1. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

2. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

3. Myotropic activity of allatostatins in tenebrionid beetles

4. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

5. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes